Inhibition of hepatic lipogenesis by adenine nucleotides

Robert Harris, R. A. Yount

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Incubation of liver slices and isolated liver cells with adenosine cyclic-3′,5′-monophosphate at concentrations which inhibit lipogenesis was found to expand the pool size of the noncyclic adenine nucleotides in the intact cells of the preparations. This observation led to studies which demonstrated that adenosine and adenosine-5′-monophosphate also inhibited lipogenesis and expanded the adenine nucleotide pool size. It is proposed but not proven that the increase in intracellular nucleotides produced by a denosine-5′-monophosphate, adenosine cyclic-3′,5′-monophosphate, and adenosine may have an adverse effect upon the synthesis of fatty acids. Because of the expansion of the adenine nucleotide pool size, high concentrations of adenosine cyclic-3′,5′-monophosphate should not be used to investigate the mechanism responsible for hormonal regulation of lipogenesis. As an added complication, exogenous adenosine-5′-monophosphate was found to produce a small but significant increase in the intracellular concentration of adenosine cyclic-3′,5′-monophosphate of isolated liver cells. This effect also may be a factor in the inhibition of lipogenesis by adenosine-5′-monophosphate. Low concentrations of N6,O2′-dibutyryl adenosine cyclic-3′,5′-monophosphate were found to inhibit lipogenesis without increasing the intracellular adenine nucleotide content of either liver slices or isolated liver cells. It is concluded that studies on the mechanism of glucagon regulation of lipogenesis should be carried out with glucagon or low concentrations of N6,O2′-dibutyryl adenosine cyclic-3′,5′-monophosphate.

Original languageEnglish
Pages (from-to)673-680
Number of pages8
JournalLipids
Volume10
Issue number11
DOIs
StatePublished - Nov 1975

Fingerprint

Lipogenesis
Adenine Nucleotides
lipogenesis
cyclic AMP
Liver
Adenosine
adenosine monophosphate
liver
Adenosine Monophosphate
hepatocytes
glucagon
adenosine
Glucagon
hormonal regulation
Cyclic AMP
adenine nucleotides
Fatty Acids
Nucleotides
nucleotides
adverse effects

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Biochemistry
  • Biochemistry, Genetics and Molecular Biology(all)
  • Food Science

Cite this

Inhibition of hepatic lipogenesis by adenine nucleotides. / Harris, Robert; Yount, R. A.

In: Lipids, Vol. 10, No. 11, 11.1975, p. 673-680.

Research output: Contribution to journalArticle

Harris, Robert ; Yount, R. A. / Inhibition of hepatic lipogenesis by adenine nucleotides. In: Lipids. 1975 ; Vol. 10, No. 11. pp. 673-680.
@article{aa96e9d58d984a2cb1aea0ec92494db5,
title = "Inhibition of hepatic lipogenesis by adenine nucleotides",
abstract = "Incubation of liver slices and isolated liver cells with adenosine cyclic-3′,5′-monophosphate at concentrations which inhibit lipogenesis was found to expand the pool size of the noncyclic adenine nucleotides in the intact cells of the preparations. This observation led to studies which demonstrated that adenosine and adenosine-5′-monophosphate also inhibited lipogenesis and expanded the adenine nucleotide pool size. It is proposed but not proven that the increase in intracellular nucleotides produced by a denosine-5′-monophosphate, adenosine cyclic-3′,5′-monophosphate, and adenosine may have an adverse effect upon the synthesis of fatty acids. Because of the expansion of the adenine nucleotide pool size, high concentrations of adenosine cyclic-3′,5′-monophosphate should not be used to investigate the mechanism responsible for hormonal regulation of lipogenesis. As an added complication, exogenous adenosine-5′-monophosphate was found to produce a small but significant increase in the intracellular concentration of adenosine cyclic-3′,5′-monophosphate of isolated liver cells. This effect also may be a factor in the inhibition of lipogenesis by adenosine-5′-monophosphate. Low concentrations of N6,O2′-dibutyryl adenosine cyclic-3′,5′-monophosphate were found to inhibit lipogenesis without increasing the intracellular adenine nucleotide content of either liver slices or isolated liver cells. It is concluded that studies on the mechanism of glucagon regulation of lipogenesis should be carried out with glucagon or low concentrations of N6,O2′-dibutyryl adenosine cyclic-3′,5′-monophosphate.",
author = "Robert Harris and Yount, {R. A.}",
year = "1975",
month = "11",
doi = "10.1007/BF02532760",
language = "English",
volume = "10",
pages = "673--680",
journal = "Lipids",
issn = "0024-4201",
publisher = "Springer Verlag",
number = "11",

}

TY - JOUR

T1 - Inhibition of hepatic lipogenesis by adenine nucleotides

AU - Harris, Robert

AU - Yount, R. A.

PY - 1975/11

Y1 - 1975/11

N2 - Incubation of liver slices and isolated liver cells with adenosine cyclic-3′,5′-monophosphate at concentrations which inhibit lipogenesis was found to expand the pool size of the noncyclic adenine nucleotides in the intact cells of the preparations. This observation led to studies which demonstrated that adenosine and adenosine-5′-monophosphate also inhibited lipogenesis and expanded the adenine nucleotide pool size. It is proposed but not proven that the increase in intracellular nucleotides produced by a denosine-5′-monophosphate, adenosine cyclic-3′,5′-monophosphate, and adenosine may have an adverse effect upon the synthesis of fatty acids. Because of the expansion of the adenine nucleotide pool size, high concentrations of adenosine cyclic-3′,5′-monophosphate should not be used to investigate the mechanism responsible for hormonal regulation of lipogenesis. As an added complication, exogenous adenosine-5′-monophosphate was found to produce a small but significant increase in the intracellular concentration of adenosine cyclic-3′,5′-monophosphate of isolated liver cells. This effect also may be a factor in the inhibition of lipogenesis by adenosine-5′-monophosphate. Low concentrations of N6,O2′-dibutyryl adenosine cyclic-3′,5′-monophosphate were found to inhibit lipogenesis without increasing the intracellular adenine nucleotide content of either liver slices or isolated liver cells. It is concluded that studies on the mechanism of glucagon regulation of lipogenesis should be carried out with glucagon or low concentrations of N6,O2′-dibutyryl adenosine cyclic-3′,5′-monophosphate.

AB - Incubation of liver slices and isolated liver cells with adenosine cyclic-3′,5′-monophosphate at concentrations which inhibit lipogenesis was found to expand the pool size of the noncyclic adenine nucleotides in the intact cells of the preparations. This observation led to studies which demonstrated that adenosine and adenosine-5′-monophosphate also inhibited lipogenesis and expanded the adenine nucleotide pool size. It is proposed but not proven that the increase in intracellular nucleotides produced by a denosine-5′-monophosphate, adenosine cyclic-3′,5′-monophosphate, and adenosine may have an adverse effect upon the synthesis of fatty acids. Because of the expansion of the adenine nucleotide pool size, high concentrations of adenosine cyclic-3′,5′-monophosphate should not be used to investigate the mechanism responsible for hormonal regulation of lipogenesis. As an added complication, exogenous adenosine-5′-monophosphate was found to produce a small but significant increase in the intracellular concentration of adenosine cyclic-3′,5′-monophosphate of isolated liver cells. This effect also may be a factor in the inhibition of lipogenesis by adenosine-5′-monophosphate. Low concentrations of N6,O2′-dibutyryl adenosine cyclic-3′,5′-monophosphate were found to inhibit lipogenesis without increasing the intracellular adenine nucleotide content of either liver slices or isolated liver cells. It is concluded that studies on the mechanism of glucagon regulation of lipogenesis should be carried out with glucagon or low concentrations of N6,O2′-dibutyryl adenosine cyclic-3′,5′-monophosphate.

UR - http://www.scopus.com/inward/record.url?scp=0016695442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016695442&partnerID=8YFLogxK

U2 - 10.1007/BF02532760

DO - 10.1007/BF02532760

M3 - Article

C2 - 172757

AN - SCOPUS:0016695442

VL - 10

SP - 673

EP - 680

JO - Lipids

JF - Lipids

SN - 0024-4201

IS - 11

ER -